What CICC Capital does

CICC Capital (legally Shanghai Zhongjin Capital Investment Co., Ltd., 上海中金资本投资有限公司) is a privately held investment management firm founded in 1997 and headquartered in Shanghai's Xuhui District. It operates as the dedicated capital operations platform of CIG Group (Zhongjin Investment (Group) Co., Ltd., 中金投资（集团）有限公司), a diversified conglomerate with approximately 10 billion RMB in managed net assets. CICC Capital manages approximately 3 billion RMB in assets under management and has cumulatively deployed over 2 billion RMB across more than 50 professional investment personnel. Its declared investment thesis centers on the elderly health industry in China, with four business segments: 中金健康 (Health Industry Investment), 中金战投 (Strategic M&A), 中金证投 (Securities Investment), and 中金创投 (Venture Capital).

The firm's product surface spans direct equity investments in senior care facilities, hospitals, medical devices, pension finance, and elderly consumption, alongside strategic M&A execution and asset securitization for portfolio companies, securities investments in listed health and education names, and early-stage venture capital. Two specialized funds anchor the platform: the Puzhen Fund (2013), focused on elderly medical care, nursing, pharmaceuticals, and medical devices, and the Orthopedic Medical Fund (2018), building regional orthopedic hospital groups via M&A in central and western China. The VC arm typically invests 2-15 million RMB per project and reports first-round institutional investor status in over 70% of deals. The portfolio includes education, consumer, and to-B technology names such as ABC360, Le En Education, Randy Children's English, Li Tao Education, Teasoon, and Ai Chong Doctor, as well as the recent Dajie Robotics Series D co-investment in industrial embodied intelligence.

The business model is a multi-strategy investment platform generating revenue through management fees on AUM, carried interest on fund exits, capital gains on balance-sheet investments, and advisory fees from M&A engagements. Go-to-market relies on direct referrals, industry networks, and the CIG Group ecosystem rather than traditional marketing. Post-investment value creation is delivered through a 'five-in-one' model combining continued capital, operational improvement (including via affiliated Bairen Health's 60+ elderly care institutions), industry research, capital market services, and resource integration. Geographic coverage spans China's Yangtze River Delta, Pearl River Delta, Beijing-Tianjin-Hebei, Chengdu-Chongqing, and central and western regions, with no overseas operations claimed.

Name

CICC Capital

Legal name

上海中金资本投资有限公司 (Shanghai Zhongjin Capital Investment Co., Ltd.)

Website

http://www.ccifund.com/

Company type

Private

Founded year

1997

Operating status

Operating

Short description

CICC Capital is a Shanghai-based private investment management firm founded in 1997, operating as the capital platform of CIG Group. It manages approximately 3 billion RMB across four segments, focusing on elderly health, strategic M&A, securities investment, and venture capital in China.

Ownership category

akta.pro rank

Product category

Investment Management

NAICS

Portfolio Management and Investment Advice (523940), Other Financial Investment Activities (5239)

SIC

Investment Advice (6282), Investors, Nec (6799)

akta.pro primary industry

Sustainable Private Markets (Impact PE/VC, Private Credit, Infrastructure) (FSAAALAG)

akta.pro secondary industry

Corporate Strategic Real Assets & Infrastructure Venture Investing (FSANAHAN)

Keywords

• Private equity investment
• Venture capital
• Strategic mergers acquisitions
• Elderly healthcare investing
• Investment management services

Headquarters

HQ city

Shanghai

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Industrial Investment: Direct investments in elderly health industry companies, including healthcare facilities, senior care services, and related sectors.
2. Strategic M&A: Strategic acquisitions and mergers in the elderly health sector, helping portfolio companies achieve asset securitization.
3. Securities Investment: Equity investments in publicly listed companies and capital market transactions in the health and education sectors.
4. Innovation Investment (VC): Venture capital investments in early-to-mid stage companies, particularly in consumer, education, and technology sectors. Single project investments range from 2 million to 15 million RMB, with over 70% of projects being first-round institutional investors.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

CICC Capital is a capital operations and equity investment platform under Zhongjin Investment (Group) Co., Ltd., managing approximately 3 billion RMB across industrial investment, strategic M&A, securities investment, and innovation investment (VC). The firm focuses on the elderly health industry with specialized sub-funds including the Puzhen Fund (elderly healthcare) and Orthopedic Medical Fund. With 50+ professional investment personnel and cumulative investments exceeding 2 billion RMB, it provides equity capital, strategic acquisitions, and post-investment value-added services to portfolio companies.

Product overview

CICC Capital is an investment management company operating as a multi-business platform under CICC Group (中金投资（集团）有限公司). The company offers four main investment business segments: Venture Capital (中金创投) for early-stage investments in consumer, education and technology sectors; Strategic Investment (中金战投) for M&A activities in health and education; Securities Investment (中金证投) for stock market investments; and Health Industry Investment (中金健康) focused on elderly care and senior health services. The company manages specialized funds including the Puzhen Fund (璞钲基金) and Orthopedic Medical Fund (骨科医疗基金), with total managed capital of approximately 3 billion RMB and over 50 professional investment personnel.

Differentiator

Problem solved

Functional benefit

Brands

• 中金健康 (Zhongjin Health): Focuses on capital operations and equity investment in elderly health industry.
• 中金战投 (Zhongjin Strategic Investment)
• 中金证投 (Zhongjin Securities Investment)
• 中金创投 (Zhongjin Venture Capital)

Products and services

• Zhongjin Health Industry Investment (中金健康) Capital operations and equity investments focused on the elderly health industry, covering elderly medical care, life care services, elderly consumption, pension finance, and pension real estate for portfolio companies in the aging population sector.
• Zhongjin Strategic Investment (中金战投) Strategic investments and mergers & acquisitions in the health and education industries, facilitating deep integration of industry and capital for enterprises seeking strategic transactions.
• Zhongjin Securities Investment (中金证投) Securities investment focusing on health and education sectors with rational investment philosophy emphasizing long-term returns and value investing principles for publicly listed companies.
• Zhongjin Venture Capital (中金创投) Venture capital investment business focusing on consumer, education, and technology sectors, managing multiple funds with investment amounts ranging from 2 million to 15 million RMB per project, with over 70% of projects being first-round institutional investments.
• Puzhen Fund (璞真基金) Specialized fund focused on elderly medical care, elderly nursing, elderly medicine, medical devices, pension real estate, pension finance, and elderly consumption industries.
• Orthopedic Medical Fund (骨科医疗基金) Specialized fund focused on orthopedic specialty medical industry in central and western regions of China, targeting secondary or tertiary orthopedic hospitals and medical device distribution enterprises, with a goal of asset securitization within 3-5 years through M&A.

Quantifiable outcome

• 投资后更通过不断优化医疗服务，提升运营效率，实现了收入和利润的大幅增长 (After investment, optimized medical services and improved operational efficiency achieved significant revenue and profit growth)
• +2 more outcomes

Segments1 record

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Bairen Health (佰仁健康)coreStrategic or Co-development Partner · 1 January 2014Subsidiary under CIG Group focused on elderly health operations. Operates nearly 60 elderly care institutions (elderly hospitals, nursing homes), dozens of community-based service points, with projects in 8 provinces and 16 cities, employing 4,000+ staff under the 'Bairentang' brand.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Hillhouse Capital: One of the largest Asia-focused investment firms with sizable healthcare and senior care exposure. Comparable to CICC Capital as a PE/VC investor in healthcare/consumer, but operates at a much larger AUM scale and broader sector mandate.
• Boyu Capital: Major Chinese private equity firm with healthcare and consumer investments. Comparable as a Chinese PE platform with diversified sector exposure, though significantly larger than CICC Capital.
• CDH Investments: Established Chinese PE firm with healthcare and consumer investments. Comparable as a Chinese PE platform investing across sectors, with greater scale and a longer track record.
• SAIF Partners: Asia-focused PE/VC firm with healthcare and consumer investments. Comparable to CICC Capital as a Chinese PE investor, though at larger scale and broader mandate.
• China Reform Holdings: State-affiliated Chinese investment platform with healthcare and infrastructure investments. Comparable to CICC Capital as a Chinese investment platform with state-linked resources, though at much larger scale.

Direct peers

• FountainVest Partners: Asia-focused private equity firm with significant healthcare and consumer investments. Comparable to CICC Capital as a thematic PE investor in healthcare/elderly services, with a similar mid-to-large AUM profile.
• Highlight Capital (HLC): Healthcare-focused private equity firm investing in biopharma, medical devices, and healthcare services in China. Directly comparable to CICC Capital's elderly health investment focus and similar AUM scale.
• Loyal Valley Capital: Chinese PE firm with healthcare and consumer investment focus. Comparable to CICC Capital in its thematic healthcare exposure and Chinese mid-market focus.
• Primavera Capital: Chinese private equity firm with healthcare and consumer investments. Comparable to CICC Capital as a mid-market Chinese PE platform with diversified sector exposure.

Emerging players

• Vivo Capital: Healthcare-focused PE firm with significant Asia operations. Comparable to CICC Capital as a healthcare-specialized PE investor, with cross-border capabilities CICC Capital lacks.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments69 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CICC Capital